Showing 1 - 5 results of 5 for search '"Venu"', query time: 0.05s Refine Results
  1. 1

    “We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs by Tyler S. Bartholomew, Barbara Andraka-Cristou, Rachel K. Totaram, Shana Harris, Susanne Doblecki-Lewis, Lily Ostrer, David P. Serota, David W. Forrest, Teresa A. Chueng, Edward Suarez, Hansel E. Tookes

    Published 2022-12-01
    “…Conclusions A mobile harm reduction setting could be an effective venue for delivering comprehensive HIV prevention services to Black PWID, a community that experiences significant barriers to care via marginalization and racism in a fragmented healthcare system.…”
    Get full text
    Article
  2. 2

    Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma by Carolina Scaramutti, Belén Hervera, Yanexy Rivera, Teresa A. Chueng, David W. Forrest, Edward Suarez, David P. Serota, Hatoun Alkamli, Katrina Ciraldo, Tyler S. Bartholomew, Hansel E. Tookes

    Published 2024-02-01
    “…Abstract Background Tele-harm reduction (THR) is a telehealth-enhanced, peer-led, harm reduction intervention delivered within a trusted syringe services program (SSP) venue. The primary goal of THR is to facilitate linkage to care and rapid, enduring virologic suppression among people who inject drugs (PWID) with HIV. …”
    Get full text
    Article
  3. 3

    Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency by Tyler S. Bartholomew, Hansel E. Tookes, Teresa A. Chueng, Ricky N. Bluthenthal, Lynn D. Wenger, Alex H. Kral, Barrot H. Lambdin

    Published 2023-09-01
    “…Federal, state, and local governments must increase funding for low-barrier venues like SSPs to support telehealth implementation to serve the needs of people who use drugs.…”
    Get full text
    Article
  4. 4

    Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study by Edward Suarez, Tyler S. Bartholomew, Marina Plesons, Katrina Ciraldo, Lily Ostrer, David P. Serota, Teresa A. Chueng, Morgan Frederick, Jason Onugha, Hansel E. Tookes

    Published 2023-12-01
    “…Our pilot suggests that an SSP may be an acceptable and feasible venue for delivery of THR to increase uptake of buprenorphine by PWID and promote retention in care.KEY MESSAGESThe Tele-Harm Reduction intervention can be adapted for initiating and retaining people who inject drugs with opioid use disorder on buprenorphine within a syringe services program settingUsing telehealth was associated with increased three-month buprenorphine retentionBaseline stimulant use was negatively associated with three-month buprenorphine retention…”
    Get full text
    Article
  5. 5

    Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs by Hansel E. Tookes, Asa Oxner, David P. Serota, Elizabeth Alonso, Lisa R. Metsch, Daniel J. Feaster, Jessica Ucha, Edward Suarez, David W. Forrest, Kathryn McCollister, Allan Rodriguez, Michael A. Kolber, Teresa A. Chueng, Sheryl Zayas, Bernice McCoy, Kyle Sutherland, Chetwyn Archer, Tyler S. Bartholomew

    Published 2023-02-01
    “…We developed Tele-Harm Reduction, a telehealth-enhanced, harm reduction intervention delivered within an SSP venue. Methods The T-SHARP trial is an open-label, multi-site, randomized controlled superiority trial with two parallel treatment arms. …”
    Get full text
    Article